315 related articles for article (PubMed ID: 33717055)
21. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
22. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway.
Chuang WY; Kung PH; Kuo CY; Wu CC
Thromb Haemost; 2013 Jun; 109(6):1120-30. PubMed ID: 23426129
[TBL] [Abstract][Full Text] [Related]
23. ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors.
Anderson R; Theron AJ; Steel HC; Nel JG; Tintinger GR
Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255391
[TBL] [Abstract][Full Text] [Related]
24. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
25. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
26. Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation
Anderson R; Theron AJ; Nel JG; Durandt C; Cholo MC; Feldman C; Tintinger GR
Front Pharmacol; 2018; 9():1335. PubMed ID: 30515097
[TBL] [Abstract][Full Text] [Related]
27. The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.
Dangelmaier C; Jin J; Daniel JL; Smith JB; Kunapuli SP
Eur J Biochem; 2000 Apr; 267(8):2283-9. PubMed ID: 10759852
[TBL] [Abstract][Full Text] [Related]
28. Enhanced platelet aggregation and activation under conditions of hypothermia.
Xavier RG; White AE; Fox SC; Wilcox RG; Heptinstall S
Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.
Dangelmaier C; Jin J; Smith JB; Kunapuli SP
Thromb Haemost; 2001 Feb; 85(2):341-8. PubMed ID: 11246558
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
33. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
Nkambule BB; Davison G; Ipp H
Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
[TBL] [Abstract][Full Text] [Related]
34. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
36. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
[TBL] [Abstract][Full Text] [Related]
37. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
[TBL] [Abstract][Full Text] [Related]
38. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol enrichment of rabbit platelets enhances the Ca(2+) entry pathway induced by platelet-derived secondary feedback agonists.
Shiraishi M; Tamura K; Egoshi M; Miyamoto A
Life Sci; 2013 May; 92(14-16):838-44. PubMed ID: 23499558
[TBL] [Abstract][Full Text] [Related]
40. Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel.
Hermann A; Rauch BH; Braun M; Schrör K; Weber AA
Platelets; 2001 Mar; 12(2):74-82. PubMed ID: 11297035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
